New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 7, 2013
10:00 EDTAWK, KWK, UNFI, SCTY, AGN, MCY, VITC, SD, GRP, FMS, DGI, DDAIF, DVA, BIG, CWHOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: American Water (AWK) downgraded to Neutral from Buy at Citigroup... Big Lots (BIG) downgraded to Hold from Buy at Canaccord... DaVita (DVA) downgraded to Hold from Buy at Deutsche Bank... Daimler AG (DDAIF) downgraded to Neutral from Buy at Citigroup... DigitalGlobe (DGI) downgraded to Hold from Buy at Benchmark Co... Fresenius Medical (FMS) downgraded to Sector Perform from Outperform at RBC Capital... Granite Real Estate (GRP) downgraded to Sector Perform from Outperform at RBC Capital... Lincoln Educational (LINC) downgraded to Underperform from Market Perform at BMO Capital... SandRidge Energy (SD) downgraded to Underperform from Market Perform at BMO Capital... Vitacost.com (VITC) downgraded to Sell from Neutral at Roth Capital... Mercury General (MCY) downgraded to Neutral from Outperform at Macquarie... Allergan (AGN) downgraded to Neutral from Buy at Buckingham... SolarCity (SCTY) downgraded to Hold from Buy at Needham... United Natural Foods (UNFI) downgraded to Hold from Buy at Argus... Quicksilver Resources (KWK) downgraded to Hold from Buy at MLV Equity... CommonWealth REIT (CWH) downgraded to Sell from Hold at Stifel Nicolaus.
News For AWK;BIG;DVA;DDAIF;DGI;FMS;GRP;SD;VITC;MCY;AGN;SCTY;UNFI;KWK;CWH From The Last 14 Days
Check below for free stories on AWK;BIG;DVA;DDAIF;DGI;FMS;GRP;SD;VITC;MCY;AGN;SCTY;UNFI;KWK;CWH the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
July 14, 2014
05:49 EDTCWHStocks with implied volatility movement; BBBY CWH
Subscribe for More Information
July 11, 2014
16:48 EDTAGNAllergan comments on Pershing Square’s definitive proxy solicitation
Allergan (AGN) provided the following comment in response to the definitive proxy solicitation filed by Pershing Square Capital Management in connection with Pershing Square’s request to call a Special Meeting of Stockholders. At the Special Meeting, if called, Allergan stockholders would be asked to remove a majority of the company’s existing directors in connection with Valeant Pharmaceuticals' (VRX) unsolicited exchange offer to acquire all outstanding common shares of Allergan for 0.83 shares of Valeant common stock and $72.00 in cash, or subject to proration, an amount of cash or a number of Valeant common shares with the implied value set forth in the exchange offer. Under the current Board’s leadership, which includes individuals with significantly more industry experience than Pershing Square’s recommended nominees, Allergan continues to execute on its plan to drive near- and long-term organic growth, enhance its growth prospects and continue generating significant value for all of Allergan’s stockholders. We believe Pershing Square’s attempt to replace a majority of the Allergan Board is a further effort to support Valeant in its bid to acquire Allergan at a grossly inadequate price that substantially undervalues the company and creates significant risks and uncertainties for Allergan stockholders. Valeant has repeatedly failed to address the serious concerns raised by Allergan and important members of the investment community about Valeant’s anemic organic growth driven by unsustainable price increases, among other fundamental business model issues. Allergan has a track record of consistently acting in the best interests of its stockholders and the Board remains confident in the company’s ability to create significantly more value than Valeant’s proposal.
11:54 EDTAGNAbbVie, Shire in active takeover talks, Bloomberg reports
AbbVie (ABBV) and Shire (SHPG) are in active talks about a potential merger after AbbVie raised its takeover offer for a fourth time, Bloomberg reports, citing people with knowledge of the matter. The talks are in the early stage and may not lead to an agreement, sources told Bloomberg. Shares of Shire are up 5%, or $12.04, to $250.65 following the report.
11:31 EDTSDOptions with increasing implied volatility
Options with increasing implied volatility: INO AEGR UBNT INVN WTW OREX GNC CREE SD SAN
11:25 EDTAWKAmerican Water downgraded to Long-Term Buy from Buy at Hilliard Lyons
Subscribe for More Information
11:19 EDTCWHOptions with decreasing implied volatility: BDSI CWH INFY MONT
Subscribe for More Information
July 10, 2014
16:06 EDTVITCGabelli reports 8.99% stake in Vitacost.com
Subscribe for More Information
11:09 EDTSDOptions with increasing implied volatility
Subscribe for More Information
10:05 EDTCWHOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:20 EDTSCTYSolarCity volatility at low end of historic range
Subscribe for More Information
08:39 EDTCWHGovernment Properties stake in SIR viewed negatively at Wells Fargo
Subscribe for More Information
06:37 EDTCWHCommonWealth sells stake in Select Income REIT for $31.51 per share
Subscribe for More Information
06:36 EDTCWHCommonWealth REIT upgraded to Buy from Hold at Stifel
Stifel upgraded CommonWealth (CWH) to Buy following the sale of its stake in Select Income REIT (SIR) for $705M. The analyst said the sale will allow the company to pay down its $735M outstanding term loan revolver and views the new CFO announcement as a positive. Price target is $28.50.
05:22 EDTAWKAmerican Water announces promising results for seawater desalination slant wells
Subscribe for More Information
July 9, 2014
18:31 EDTAGNShareholders urge Allergan to make large acquisition, FT reports
Subscribe for More Information
18:21 EDTAGNAllergan CEO seeks sizeable acquisitions, WSJ reports
Subscribe for More Information
11:24 EDTKWKHigh option volume stocks
High option volume stocks: GIMO NEPT BPOP AVAV CBSO LL BOBE KWK GNC TCS
06:19 EDTAGNAllergan plans broad restructuring plan, Bloomberg says
Allergan (AGN), the pharmaceutical maker that is being chased by Valeant (VRX) and Bill Ackman’s hedge fund, will shelve unpromising pipeline medicines and revamp management incentives, according to Bloomberg, citing two people with knowledge of the matter. The sources said that the restructuring plan, which is set to be explained during Allergan's upcoming earnings announcement, will also detail companywide cost reductions including some legacy expenses. Reference Link
06:07 EDTDDAIFDaimler could introduce self-driving trucks as early as 2025, Detroit News says
Subscribe for More Information
05:56 EDTSDStocks with implied volatility movement; YELP SD
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use